SCHEMBL256014

SCHEMBL256014

CCc1ccc(Cl)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19677275 0.86 KDM4E (0.40)
SCHEMBL8284899 0.80
SCHEMBL45854 0.80
SCHEMBL8671567 0.78 MMP8 (0.46)
SCHEMBL190205 0.76
SCHEMBL25080869 0.75 HTT (0.42)
SCHEMBL12768200 0.75 FFAR1 (0.40)
SCHEMBL8449242 0.75 TAAR1 (0.45)
SCHEMBL282133 0.74
SCHEMBL5260460 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024305-A1 METHODS AND COMPOSITIONS FOR TREATING RETINA-ASSOCIATED DISEASE USING CCR3-INHIBITORS ALKAHEST, INC. 2024-01-25 US disclosed
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP disclosed
US-20230346764-A1 Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors ALKAHEST, INC. 2023-11-02 US disclosed
US-20230339913-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. 2023-10-26 US disclosed
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 US disclosed
US-11737463-B2 Pyridine and pyrazine compounds BASF SE (DE) 2023-08-29 US disclosed
US-11586060-B2 Optical filter with light source SOLUTIA CANADA INC. (CA) 2023-02-21 US disclosed
US-20230045960-A1 SUBSTITUTED HETEROAROMATIC PYRAZOLO-PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-02-16 US disclosed
US-20230043959-A1 PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS INCYTE CORPORATION 2023-02-09 US disclosed
EP-3842420-B1 HETEROARYL INHIBITORS OF PDE4 TETRA DISCOVERY PARTNERS LLC (US) 2022-12-07 EP disclosed
EP-0008077-B1 PROSTAGLANDIN DERIVATIVES WITH A DELTA-2-PGF2 STRUCTURE OR A DELTA-2-PGE2 STRUCTURE, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST AKTIENGESELLSCHAFT (DE) 1983-11-16 EP disclosed
EP-0065200-A2 Thiolactime ethers of delta-1-pyrrolidine, and their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1982-11-24 EP disclosed
EP-0055851-A1 11-Deoxy-hetero-imino-prostacyclins, processes for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1982-07-14 EP disclosed
US-4312882-A ANTICOAGULANTS, HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1982-01-26 US disclosed
US-4304783-A ANTITHROMBOTIC, ANTIINFARCT, HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1981-12-08 US disclosed
US-4296121-A HYPOTENSIVE AGENTS, ANTICOAGULANTS HOECHST AKTIENGESELLSCHAFT (DE) 1981-10-20 US disclosed
EP-0029527-A2 Prostaglandin derivatives of the 6-keto-PGA1 series, process for their production as well as their use in medicaments and their intermediate products HOECHST AKTIENGESELLSCHAFT (DE) 1981-06-03 EP disclosed
EP-0019069-A2 6-Keto PGE1 compounds, their preparation and therapeutic application, PGI1 compounds HOECHST AKTIENGESELLSCHAFT (DE) 1980-11-26 EP disclosed
EP-0013955-A1 Analogues of prostacyclin, their intermediates, a process for their preparation and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1980-08-06 EP disclosed
EP-0008077-A2 Prostaglandin derivatives with a delta-2-PGF2 structure or a delta-2-PGE2 structure, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1980-02-20 EP disclosed